Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin

Mol Carcinog. 1999 Nov;26(3):150-6.

Abstract

The ras proto-oncogene family products are membrane-associated, guanine nucleotide-binding proteins that serve as a molecular switch for signal transduction pathways in a diverse array of organisms. In the mouse skin two-stage carcinogenesis model, a specific point mutation in Ha-ras codon 61 is responsible for the initiation event. Here we investigated whether Ha-ras protein and mRNA expression change during premalignant progression. Also, we assessed the Ha-ras mutated allele after these changes. To those ends, we analysed the Ha-ras expression profiles in normal and hyperplastic skin, papillomas, and squamous cell carcinomas by western blotting, reverse transcription-polymerase chain reaction, and in situ hybridization. Increased levels of Ha-ras expression were observed at specific times during promotion. These changes were followed by an increase in the level of expression of the Ha-ras mutated allele. These results suggest that increased expression of Ha-ras mutated alleles may have an important role during premalignant progression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles
  • Animals
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / pathology
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Genes, ras / genetics*
  • Mice
  • Mice, Inbred SENCAR
  • Mutation / genetics*
  • Papilloma / genetics
  • Papilloma / pathology
  • Precancerous Conditions / genetics*
  • Precancerous Conditions / pathology
  • Proto-Oncogene Proteins p21(ras) / biosynthesis
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • RNA, Messenger / biosynthesis
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology

Substances

  • RNA, Messenger
  • Proto-Oncogene Proteins p21(ras)